首页> 外国专利> METHOD FOR PREDICTING RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT

METHOD FOR PREDICTING RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT

机译:手术治疗后预测子宫内膜异常卵巢囊肿复发的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, in particular to gynecology, and is intended to predict the recurrence of endometrioid ovarian cysts after surgical treatment. Intraoperatively, the peritoneal fluid is collected. The method for enzyme-linked immunosorbent assay determines the concentration of vascular endothelial growth factor (VEGF). When VEGF is expressed at 125.6 pg/ml or more, the concentration of tumor necrosis factor alpha (TNFα) is additionally determined. With a TNFα value of 1.725 pg/ml or more, recurrence of endometrioid ovarian cysts is predicted.;EFFECT: invention improves the accuracy of predicting the recurrence of the endometrioid ovarian cyst after the performed surgical treatment.;1 cl, 4 ex
机译:田地:药物。物质:发明涉及医学,特别是妇科,并且旨在预测手术治疗后的子宫内甲状腺样虫卵巢囊肿的复发。 术中,收集腹膜液。 酶联免疫吸附测定方法决定了血管内皮生长因子(VEGF)的浓度。 当VEGF以125.6 pg / ml或更高表示时,另外确定肿瘤坏死因子α(TNFα)的浓度。 具有1.725pg / ml或更高的TNFα值,预测子宫内膜异形卵巢囊肿的复发。;效果:发明提高了在进行的手术治疗后预测子宫内膜异形卵巢囊肿复发的准确性。; 1 cl,4 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号